The Israel Penn International Transplant Tumor Registry
نویسندگان
چکیده
The Israel Penn International Transplant Tumor Registry is literally the world's premier repository of information on patients who have developed malignancies after organ transplants. The administrators of the Registry not only collect information but also provide consulting services based on the accumulated knowledge that the Registry contains. By creating a secure Web-based front end, we have made it possible for the Registry to keep pace with its burgeoning international caseload.
منابع مشابه
De novo malignant tumors in organ transplant recipients.
FOLLOWING THE INITIAL REPORTS of de novo malignancies in transplant recipients in 1968,1-3 an informal tumor registry for such cases was established in Denver.4 To date, accounts of malignant neoplasms in 39 renal recipients have been compiled from our own program or else submitted by a number of other groups to this registry (Tables 1 and 2). One patient has developed a carcinoma of the stomac...
متن کاملExtended criteria donors: the case for liver procurement in donors with a central nervous system malignancy.
In the December issue of Liver Transplantation, Durand et al. extensively reviewed the issue of extended criteria donors in liver transplantation. They mentioned the problem of donors with a history of malignancy and recommended in Table 2 that donors with grade III/IV central nervous system (CNS) malignant tumors be rejected as the risk of malignancy transmission is estimated at 40%. This esti...
متن کاملA summary of the status of de novo cancer in transplant recipients.
I N 1968 an informal registry was started in Denver to record all tumors which occurred in organ homograft recipients, including preexisting malignancies, inadvertently transplanted tumors, and lesions arising de novo after transplantation. Physicians from transplant centers throughout the world have generously contributed data concerning their patients. The presen~ report deals with cases reco...
متن کاملLiver graft procurement in donors with central nervous system cancers.
The recent study by Kashyap et al. confirmed with a large, single-center experience that donors with central nervous system (CNS) tumors should be proposed for liver donation, as we recently advocated. In their series of 42 liver donors with CNS tumors and a mean follow-up of 29 months, 20 donors had grade IV astrocytoma or glioblastoma multiforme, and none of the recipients developed recurrenc...
متن کاملUrothelial Carcinoma in Renal Transplant Recipients
The risk of renal transplant recipients to develope malignant disease is significantly higher than these in general population. The incidence of malignancy is estimated to be around 1520% of renal recipients 10 years after renal transplantation and increases as high as 49.6% after 20 years.(Alberu, 2010; Kapoor, 2008; Penn, 2000; Gaya, et al, 1995). The most common malignancies are skin carcino...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- AMIA ... Annual Symposium proceedings. AMIA Symposium
دوره شماره
صفحات -
تاریخ انتشار 2003